Thorac Cardiovasc Surg 2017; 65(S 03): S183-S186
DOI: 10.1055/s-0037-1601048
Tribute
Georg Thieme Verlag KG Stuttgart · New York

Conventional Aortic Valve Replacement: Standard Therapy in the 1990s and the Development of Minimally Invasive Approaches

Thomas Walther
1   Department of Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany
,
Rüdiger Autschbach
2   Department of Cardiac Surgery, University Aachen, Aachen, Germany
› Author Affiliations
Further Information

Publication History

24 February 2017

24 February 2017

Publication Date:
07 April 2017 (online)

Aortic valve replacement (AVR) was established in the 1960s as a routine therapy to treat patients with relevant aortic valve dysfunction. During the consecutive years, different generations of mechanical and biological valves were developed. In the 1990s, these developments led to several standardized stented prostheses which were routinely available ([Fig. 1]). In parallel, AVR has developed as a routine procedure with low morbidity and mortality in experienced centers. Similar to today's practice aortic stenosis was the underlying pathology in the vast majority of patients. Conventional bileaflet mechanical valves or stented bioprostheses were routinely used to replace severely calcified native valve cusps. AVR was usually performed using full sternotomy access and cardiopulmonary bypass support. While excellent patient safety and good patient outcomes were reached with these standardized procedures, there seemed to be little potential for further innovations and improvements in that field.

Zoom Image
Fig. 1 Mechanical valves (left upper two), conventional stented bioprostheses (left lower two), and stentless Toronto porcine bioprosthesis (right).
 
  • References

  • 1 David TE, Bos J, Rakowski H. Aortic valve replacement with the Toronto SPV bioprosthesis. J Heart Valve Dis 1992; 1 (2) 244-248
  • 2 Mohr FW, Walther T, Baryalei M , et al. The Toronto SPV bioprosthesis: one-year results in 100 patients. Ann Thorac Surg 1995; 60 (1) 171-175
  • 3 Walther T, Falk V, Autschbach R , et al. Hemodynamic assessment of the stentless Toronto SPV bioprosthesis by echocardiography. J Heart Valve Dis 1994; 3 (6) 657-665
  • 4 Walther T, Falk V, Langebartels G , et al. Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy. Circulation 1999; 100 (19, Suppl): II6-II10
  • 5 Walther T, Schubert A, Falk V , et al. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression. Circulation 2001; 104 (12) (Suppl. 01) I54-I58
  • 6 Walther T, Schubert A, Falk V , et al. Left ventricular reverse remodeling after surgical therapy for aortic stenosis: correlation to Renin-Angiotensin system gene expression. Circulation 2002; 106 (12) (Suppl. 01) I23-I26
  • 7 Autschbach R, Walther T, Falk V , et al. Prospectively randomized comparison of different mechanical aortic valves. Circulation 2000; 102 (19) (Suppl. 03) III1-III4
  • 8 Walther T, Lehmann S, Falk V , et al. Experimental evaluation and early clinical results of a new low-profile bileaflet aortic valve. Artif Organs 2002; 26 (5) 416-419
  • 9 Walther T, Falk V, Tigges R , et al. Comparison of On-X and SJM HP bileaflet aortic valves. J Heart Valve Dis 2000; 9 (3) 403-407
  • 10 Walther T, Lehmann S, Falk V , et al. Prospectively randomized evaluation of stented xenograft hemodynamic function in the aortic position. Circulation 2004; 110 (11) (Suppl. 01) II74-II78
  • 11 Lehmann S, Walther T, Kempfert J , et al. Stentless versus conventional xenograft aortic valve replacement: midterm results of a prospectively randomized trial. Ann Thorac Surg 2007; 84 (2) 467-472
  • 12 Autschbach R, Walther T, Falk V, Diegeler A, Metz S, Mohr FW. S-shaped in comparison to L-shaped partial sternotomy for less invasive aortic valve replacement. Eur J Cardiothorac Surg 1998; 14 (Suppl. 01) S117-S121
  • 13 Doll N, Borger MA, Hain J , et al. Minimal access aortic valve replacement: effects on morbidity and resource utilization. Ann Thorac Surg 2002; 74 (4) S1318-S1322
  • 14 Walther T, Falk V, Metz S , et al. Pain and quality of life after minimally invasive versus conventional cardiac surgery. Ann Thorac Surg 1999; 67 (6) 1643-1647
  • 15 Lim JY, Deo SV, Altarabsheh SE , et al. Conventional versus minimally invasive aortic valve replacement: pooled analysis of propensity-matched data. J Card Surg 2015; 30 (2) 125-134
  • 16 Phan K, Xie A, Di Eusanio M, Yan TD. A meta-analysis of minimally invasive versus conventional sternotomy for aortic valve replacement. Ann Thorac Surg 2014; 98 (4) 1499-1511
  • 17 Glauber M, Ferrarini M, Miceli A. Minimally invasive aortic valve surgery: state of the art and future directions. Ann Cardiothorac Surg 2015; 4 (1) 26-32